Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 3/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.40 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 2/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28856641 | 1.00 | SLC7A5 (0.47) | SLC7A5ANPEPRNPEPDNPEPMME | |
| SCHEMBL2489676 | 1.00 | SLC7A5 (0.47) | SLC7A5ANPEPRNPEPDNPEPMME | |
| Isothiocyanate SCHEMBL2490540 | 0.91 | SLC7A5 (0.45) | SLC7A5ANPEPRNPEPDNPEPMME | |
| SCHEMBL700933 | 0.90 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPMME | |
| SCHEMBL196338 | 0.90 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPMME | |
| SCHEMBL76796 | 0.90 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPMME | |
| SCHEMBL29783468 | 0.90 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPMME | |
| Hydrochloric Acid SCHEMBL353346 | 0.88 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPMME | |
| Hydrochloric Acid SCHEMBL76795 | 0.88 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPMME | |
| Hydrochloric Acid SCHEMBL355415 | 0.88 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8059592-A | — | — | None | — | — | JP | disclosed |
| CN-115667215-B | Broad-spectrum antiviral medicine for resisting coronavirus | 堪萨斯州立大学研究基金会 | 2026-05-19 | — | — | CN | disclosed |
| US-12583820-B2 | Broad spectrum antivirals against coronavirus | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2026-03-24 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230150933-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2023-05-18 | — | — | US | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| US-20230135772-A1 | CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4126816-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | Kansas State University Research Foundation (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-4130154-A1 | CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT | Asahi Kasei Kabushiki Kaisha (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-115667215-A | Broad-spectrum antiviral medicine for resisting coronavirus | 堪萨斯州立大学研究基金会 | 2023-01-31 | — | — | CN | disclosed |
| US-20080221123-A1 | Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and Methods of Treatment | YALE UNIVERSITY | 2008-09-11 | — | — | US | disclosed |
| EP-1427418-A4 | PIPERAZINONE COMPOUNDS AS ANTI-TUMOR AND ANTI-CANCER AGENTS AND METHODS OF TREATMENT | UNIV YALE (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-1427418-A2 | PIPERAZINONE COMPOUNDS AS ANTI-TUMOR AND ANTI-CANCER AGENTS AND METHODS OF TREATMENT | YALE UNIVERSITY (US) | 2004-06-16 | — | — | EP | disclosed |
| WO-2003017939-A2 | PIPERAZINONE COMPOUNDS AS ANTI-TUMOR AND ANTI-CANCER AGENTS AND METHODS OF TREATMENT | YALE UNIVERSITY (US) | 2003-03-06 | — | — | WO | disclosed |
| JP-H0859592-A | LEUCINE-ALKYL ESTER ISOCYANATE, ITS PRODUCTION AND POLYMER THEREOF | AIBAITSU KK | 1996-03-05 | — | — | JP | disclosed |
| US-4740611-A | N,N'-disubstituted ureas | THE STANDARD OIL COMPANY (US) | 1988-04-26 | — | — | US | disclosed |
| US-4705864-A | Aryl oxime derivatives of hydantoins | THE STANDARD OIL COMPANY (US) | 1987-11-10 | — | — | US | disclosed |
| US-4691007-A | HUMAN LEUKOCYTE ELASTASE INHIBITORS | ICI AMERICAS INC. (US) | 1987-09-01 | — | — | US | disclosed |
| US-4596789-A | Pharmaceuticals | ICI AMERICAS INC. (US) | 1986-06-24 | — | — | US | disclosed |
| EP-0124317-A2 | Proline derivatives | ICI AMERICAS INC. (US) | 1984-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583820-B2 | Broad spectrum antivirals against coronavirus | SARS1, NSUN2, ZC3HAV1 | SLC7A5 852/4885ANPEP 1527/4885RNPEP 1664/4885 |
| US-20080221123-A1 | Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and Methods of Treatment | EP300, HDAC5, VHL | SLC7A5 4513/4885ANPEP 2132/4885RNPEP 3928/4885 |
| US-20230150933-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | SARS1, ZC3HAV1, POLL | SLC7A5 1182/4885ANPEP 843/4885RNPEP 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.